Older age linked to depression risk in glaucoma patients

Article

Older glaucoma patients are more at risk of developing depression, whereas younger patients are more at risk of anxiety

Older glaucoma patients are more at risk of developing depression, whereas younger patients are more at risk of anxiety, according to a paper in the British Journal of Ophthalmology.

The stepwise linear regression analysis, led by Dr Fumihiko Mabuchi, Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Japan, included 208 glaucomatous patients. Each participant was evaluated using the hospital anxiety and depression (HADS) questionnaire split into two subscales- the HADS-anxiety (HADS-A) and HADS-depression (HADS-D).

For both HADS-A and HADS-D the regression analysis revealed that age was a significant related factor. The correlation between age and HADS-A was proven by the results of the multiple linear regression analysis.

Overall, younger glaucoma patients were more likely to suffer from anxiety, whereas older glaucoma patients were more at risk of depression.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.